Skip to main content
. 2019 Sep 6;90(3):259–265. doi: 10.23750/abm.v90i3.7601

Table 1.

Characteristics of the 61 Bariatric Surgery (BS) cases included in the analysis. Confrontations were performed through Student’s t test for unpaired data for continuous variables and by means of Chi squared test or Fisher’s test (= *) for dichotomous variables

All cases (n=61, 100%) NP (n=7, 11.5%) Non-NP (n=54, 88.5%) p value
Age (years; mean±SD) 41.8±11.4 42.7±13.9 41.7±11.2 0.831
Female Sex (n, %) 50, 82.0% 6, 85.7% 44, 81.5% 1.000
Smoking history (n, %) 8, 26.7% 0, - 8, 30.8% 0.550*
Diabetes (n, %) 10, 16.4% 2, 28.6% 8, 14.8% 0.702
Surgical procedure 0.963
Gastric banding 31, 50.8% 3, 42.9% 51.9%
Gastric bypass 30, 49.2% 4, 57.1% 48.1%
BMI TO (Kg/m2; mean±SD) 44.4±7.2 44.3±3.8 44.4±7.6 0.969
BMI T1(Kg/m2; mean±SD) 32.7±4.9 32.0±5.1 32.8±4.9 0.719
T2 data
EWL (%) 59.8±22.3 61.9±30.8 59.5±21.4 0.843
Vitamin B1 (nmol/L) 113.3±36.3 111.5±37.1 126.8±28.3 0.297
Vitamin B2 (^g/L) 258.1±76.7 213.7±72.2 263.9.±76.0 0.103
Vitamin B6 (^g/L) 19.6±5.1 17.2±3.3 19.9±5.2 0.185
Vitamin B12 (pg/mL) 249.1±101.3 251.3±99.3 260.3±106.4 0.829
SF-36 (TO) 478.3±160.2 344.5±146.5 495.6±154.8 0.018
SF-36 (T+24) 686.8±152.4 589.6±167.5 699.4±147.3 0.141

Notes: NP=neuropathic pain; Non-NP=non neuropathic pain; BMI=Body Mass Index (Kg/m2); T0=Before Surgery; T1=at follow up (12 months after surgery); SF-36=Short Form (36) Health Survey; EWL=Percent excess body weight lost